Vaccine Update Newsletter Archive
Vaccine Resources: State Policies Webpage, Communicating with H.E.A.R.T., HPV Videos, and Maternal Immunization Toolkit
Check out updated resources for state immunization policies and public health communications, and find new patient-facing tools.
From the Media: “Advisory Committee on Immunization Practices at a Crossroads”
Check out a JAMA Viewpoint article authored by the 17 ACIP committee members removed by RFK Jr. in June 2025.
VEC Announcements
Find registration for the upcoming VEC webinar and check out new webpages and vaccine-positive posters.
On the Bookshelf — “Misguided: Where Misinformation Starts, How It Spreads, and What to Do About It”
In this book, Matthew Facciani unpacks the role of identity, belonging and empathy in understanding how misinformation is shared and, in some cases, embraced.
Technically Speaking: “The Evidence-Based Child and Adolescent Immunization Schedule”
Find out about the vaccine schedule published by the American Academy of Pediatrics for children and adolescents.
In the Journals: Largest Study to Date of Aluminum-Adjuvanted Vaccines Finds No Associated Health Risks
Read about a study that found no increased health risks associated with aluminum adjuvants used in vaccines over a 24-year period.
News & Views — Hepatitis B: "Fast Facts" for Healthcare Providers
Find key facts about hepatitis B, including its infectiousness and key reasons for early childhood vaccination.
In the Journals: Do We Need More Placebo-Controlled Trials for COVID-19 Vaccines?
Read Dr. Offit’s interpretation of retrospective studies of COVID-19 vaccine effectiveness.
Vaccine Resources: Infographics, Toolkits, Webinars, and the Vaccine Integrity Project
Check out resources to support conversations about whooping cough and measles. Take a crash course in podcasting, and more!
Technically Speaking: 75 Years of Placebo-Controlled Vaccine Testing in the U.S.
Check out an interview with Dr. Gräbenstein, a pharmacist who specializes in vaccines. Drs. Gräbenstein and Humiston discussed placebo-controlled vaccine trials.